| Name | Aβ-IN-5 |
|---|
| Description | Aβ-IN-5 (Compound e12) is an orally active Aβ aggregation inhibitor. Aβ-IN-5 also inhibits AChE and BuChE with IC50 values of 21.29 μM and 1.32 μM, respectively. Aβ-IN-5 shows excellent neuroprotective effects and low neurotoxicity[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 1.32 μM (BuChE), 21.29 μM (AChE)[1] |
| In Vitro | Aβ-IN-5 (Compound e12) (25 μM) exhibits significant inhibition of Aβ aggregation with an inhibitory rate of 72%[1]. |
| In Vivo | Aβ-IN-5 (Compound e12) (15 mg/kg; p.o.) restores learning and memory function and exhibits no acute toxicity in vivo[1]. |
| References |
| Molecular Formula | C21H20N2O3 |
|---|---|
| Molecular Weight | 348.40 |